Doctor Refusal Navigator
Your doctor said no.
Here is what to do.
You are not alone. Only 40% of women who ask their GP for HRT actually receive it (PMC/NCBI, 2023). A refusal is often a training gap, not a medical verdict. This navigator gives you the evidence, the language, and the next steps.
40%
of women who ask their GP for HRT actually receive it
PMC/NCBI Qualitative Study, 2023
30%
of women who seek menopause help experience delays in diagnosis
UK Gov. Survey, 100,000 women, 2021
91%
did not feel they had enough information about menopause from their provider
UK Government Women's Health Survey, 2021
48%
of patients cited cancer concerns as the primary reason HRT was declined
Cureus/PMC, HRT Concerns Study, Nov 2025
NAMS and ACOG position (2022, updated 2024): Current NAMS and ACOG guidance indicates that for many women under 60 or within 10 years of menopause, the benefits of HRT may outweigh the risks, depending on individual medical history. Cancer fears rooted in the 2002 WHI study are based on data now considered outdated by both organizations.
Why This Happens
Six reasons doctors refuse HRT, and what each one actually means.
01
Outdated WHI study fear
The 2002 Women's Health Initiative study caused widespread HRT avoidance. Modern re-analysis shows the original study used older women (average age 63) and synthetic progestins no longer commonly prescribed. Current NAMS and ACOG guidelines reflect this correction.
Source: NAMS 2022 Hormone Therapy Position Statement
02
Insufficient menopause training
Most US medical schools provide minimal menopause education. A provider may be excellent in their specialty while genuinely undertrained in menopause management. This is a system failure, not a personal one.
Source: Let's Talk Menopause / NAMS Provider Education
03
"Your labs are normal"
Hormone testing is not always required, depending on symptoms and clinical context. NAMS and ACOG both recommend treating symptoms, not numbers. FSH and estradiol levels fluctuate widely during perimenopause and a single normal result is not diagnostic.
Source: The Menopause Society Position Statement, 2022
04
"You are too young"
Perimenopause begins on average at age 47 but can start in the late 30s. Early menopause (before 45) affects approximately 5% of women; premature menopause (before 40) affects 1%. All are candidates for HRT evaluation.
Source: ACOG Practice Bulletin, Menopause 2024
05
Genuine contraindications
Some refusals are clinically appropriate: active breast cancer, unexplained vaginal bleeding, active liver disease, or prior hormone-sensitive clots. If your doctor cited a specific medical reason, this warrants further discussion with a menopause specialist, not dismissal.
Source: NAMS 2022 Hormone Therapy Position Statement
06
Time and liability pressure
Primary care appointments average 18 minutes. Menopause discussions require nuance, risk-benefit conversations, and follow-up. Some providers decline to start a complex treatment protocol they feel they cannot adequately manage in the time available.
Source: PMC Barriers to Menopause Care Study, 2023
Treatment Options
What are your HRT options? A quick guide.
Not all HRT is the same. Understanding the difference between FDA-approved and compounded options helps you ask for what you want at your next appointment. Discuss all options with a qualified clinician.
FDA-Approved
Regulated, standardized, studied
Manufactured by pharmaceutical companies and approved by the FDA. Dosage is standardized and batch-tested. Most insurance covers FDA-approved HRT.
- Patch (estradiol): Lowest blood clot risk, steady hormone levels
- Pill (oral estradiol): Most common, convenient, widely studied
- Gel/Spray: Absorbed through skin, flexible dosing
- Vaginal ring/cream: Localized treatment for genitourinary symptoms
Offered by: Midi Health, Alloy, Evernow
Compounded Bioidentical
Custom-formulated, not FDA-reviewed
Mixed by a compounding pharmacy to your specific prescription. Customizable dosing, but not reviewed by the FDA for safety, efficacy, or consistency. Usually cash-pay.
- Custom-dose creams: Applied to skin, custom-mixed per prescription
- Troches/lozenges: Dissolved in mouth, rapid absorption
- Sublingual drops: Under-tongue delivery, fast-acting
- Combination formulas: Estrogen + progesterone in one dose
Specialty: Winona (primary model), some Midi Health clinicians
Important: This is general educational information, not medical advice. Which HRT type is appropriate for you depends on your medical history, risk factors, and clinician assessment. NAMS and ACOG both recommend FDA-approved options as first-line treatment for most candidates. Compounded HRT may be appropriate when FDA-approved options are not suitable due to allergies, dosing needs, or ingredient sensitivities.
Decision Tree
Your doctor said no. Now what?
Follow the path that matches your situation. Each route leads to a concrete next action.
Start here
"My doctor refused to discuss or prescribe HRT for my symptoms."
Route A: Get a Second Opinion
If your symptoms are manageable and you have time
Request a dedicated menopause consultation appointment with your current provider, or search The Menopause Society's MSCP-certified practitioner directory for a specialist near you.
- Search menopause.org for a certified practitioner
- Request a longer appointment focused solely on menopause
- Bring the NAMS Patient Guide to your appointment
- Ask specifically: "What would need to change for you to consider HRT?"
Route B: Telehealth Today
If your symptoms are disrupting daily life
Access a menopause-trained clinician via telehealth. No referral, no waitlist. Most platforms complete intake and prescribe within 24-72 hours if clinically appropriate.
- Midi Health: accepts most PPO insurance, video appointments
- Alloy: FDA-approved HRT, all 50 states, async, $75/month flat
- Winona: compounded bioidentical, async, $54-199/month
- Evernow: lowest entry cost, async, from $35/month membership
↓
Route C: Request Specific Reasons in Writing
If your doctor cited a medical contraindication
Ask for the specific clinical reason documented in your notes. This protects you and creates a record. Common legitimate contraindications include active breast cancer, unexplained bleeding, recent blood clot, or active liver disease.
- Ask: "Can you document the clinical reason in my chart?"
- Request a referral to a gynecologist or endocrinologist
- Seek a second opinion from an MSCP-certified provider
- Review your record via your patient portal
Route D: Change Providers
If your doctor dismissed you without clinical reason
You are entitled to seek care from a provider trained in menopause. Dismissal without clinical justification is not acceptable care. Document what was said and find a provider who will engage with your symptoms seriously.
- Use MSCP directory: menopause.org/find-a-practitioner
- Consider telehealth for immediate access (see Route B)
- File a formal complaint with your insurance if applicable
- Download our Pre-Appointment Toolkit for your next visit
↓
In all cases
Track your symptoms before your next appointment
Providers respond better to documented patterns than to described experiences. Our free 12-week symptom log template creates an objective record of frequency, severity, and functional impact. Download it below with the Doctor Refusal Toolkit.
Appointment Scripts
What to say when your doctor uses these phrases.
These responses are based on current NAMS, ACOG, and Menopause Society guidelines. Copy them, print them, bring them to your appointment.
When your doctor says
"Your labs are normal, so you don't need HRT."
Your response
"I understand my labs are in range. I'd like to discuss what NAMS and ACOG recommend, which is treating symptoms rather than hormone levels. Estradiol and FSH fluctuate widely during perimenopause, and a single normal result doesn't mean my symptoms aren't hormonally driven. Can we discuss the options?"
When your doctor says
"HRT causes breast cancer. I won't prescribe it."
Your response
"I've read that NAMS and ACOG updated their position based on re-analysis of the WHI study. The original study used women averaging age 63 and synthetic progestins. For many women under 60 or within 10 years of menopause, current NAMS and ACOG guidance suggests benefits may outweigh risks, depending on individual history. Can we discuss my individual risk profile?"
When your doctor says
"You're too young to be in menopause."
Your response
"I understand that full menopause is defined as 12 months without a period. But perimenopause can begin in the late 30s and cause significant symptoms. I am not asking for a diagnosis of menopause; I am asking for help with symptoms I've been tracking for [X months], which are impacting my sleep, mood, and quality of life."
When your doctor says
"Let's wait and see if it gets worse."
Your response
"I appreciate the conservative approach. I'd like to understand what specific threshold would change your recommendation. My symptoms are already affecting my work and sleep, and I've been tracking them for [X weeks]. I'd like to discuss whether there are lower-risk starting options we could try in the meantime."
Free Download
The Doctor Refusal Toolkit
Everything you need to advocate for yourself at your next appointment, or after your doctor has already said no. Built with NAMS-aligned clinical sources. Used by thousands of women.
NAMS-aligned evidence packet: citations and current guidelines to bring to any appointment
Pre-written talking points: the four scripts above, formatted to print and bring
12-week symptom log template: document frequency, severity, and functional impact
State-by-state telehealth map: which providers are licensed in your state today
Post-refusal decision tree: this page, formatted as a printable PDF
Get the Free Toolkit
No credit card. No spam. Unsubscribe anytime.
Still Not Sure?
Your situation is unique. Get matched.
Our Access Finder Quiz matches you to the right provider based on your insurance, state, symptoms, and preferences. Takes 2 minutes. No email required to see results.
Matches you by
- Insurance type (PPO, HSA, cash-pay)
- Your state (provider availability)
- Treatment preference (FDA vs compounded)
- Appointment style (video vs async)
- Symptom severity and timeline
Or Browse All Providers Directly
Four telehealth providers who specialize in menopause. No referral needed.
Midi Health
Insurance accepted
$0 to $250/visit depending on coverage. Video appointments. Select states.
Compare in full detail →
Alloy
$75/month flat
FDA-approved HRT only. All 50 states (verify current availability). Async intake. No bloodwork required.
Compare in full detail →
Winona
$54 to $199/month
Compounded bioidentical HRT. All 50 states (verify current availability). Async. No bloodwork required per their published process.
Compare in full detail →
Evernow
From $35/month
FDA-approved. Membership-based. Async primary model. FSA/HSA eligible.
Compare in full detail →
Pricing based on public provider information as of May 2026. Verify directly with providers. Updated monthly. TheMenopauseIndex.org may earn affiliate commissions. This never affects our rankings.